Cervarix
AssetAlso Cervarix TM, Cervarix vaccine, CervarixTM, HPV (Types 16, 18) Vaccine, Adsorbed
Recombinant vaccine preventing infection by oncogenic human papillomaviruses
- Stage
- Phase 3
- Modality
- Vaccine
- Target
- Not known
- 3
- Indications
- 25
- Trials
- 2
- Developers
Indications
3Cervical intraepithelial neoplasia
Phase 3, Completed, NCT03629886, clinicaltrials.gov, 7 Oct 2026
Human papillomavirus vaccine
Phase 3, Completed, NCT06345885, clinicaltrials.gov, 7 Oct 2026
Papillomavirus infection
Phase 3, Completed, NCT00578227, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners2
- Trials25
- Evidence for its targets1
- Competitors2
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 7 Oct 2026, 5 sources